{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:03:51Z","timestamp":1791669831631,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N020588\/1"],"award-info":[{"award-number":["MR\/N020588\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Duchenne Now"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12887-019-1503-x","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T09:05:55Z","timestamp":1556183155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"19","author":[{"given":"C. L.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. D","family":"Cheetham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. G","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ailins-Sahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Punniyakodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mayhew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"1503_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","volume":"71","author":"JR Mendell","year":"2012","unstructured":"Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J, et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol. 2012;71:304\u201313.","journal-title":"Ann Neurol"},{"key":"1503_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77\u201393.","journal-title":"Lancet Neurol"},{"key":"1503_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9:177\u201389.","journal-title":"Lancet Neurol"},{"key":"1503_CR4","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/0883073810371004","volume":"25","author":"RT Moxley 3rd","year":"2010","unstructured":"Moxley RT 3rd, Pandya S, Ciafaloni E, Fox DJ, Campbell K. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol. 2010;25:1116\u201329.","journal-title":"J Child Neurol"},{"key":"1503_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbadis.2006.06.009","volume":"1772","author":"KR Wagner","year":"2007","unstructured":"Wagner KR, Lechtzin N, Judge DP. Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta - Mol Basis Dis. 2007;1772:229\u201337.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"1503_CR6","doi-asserted-by":"crossref","unstructured":"Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2008:CD003725.","DOI":"10.1002\/14651858.CD003725.pub3"},{"key":"1503_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","volume":"16","author":"WD Biggar","year":"2006","unstructured":"Biggar WD, Harris VA, Eliasoph L, Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord. 2006;16:249\u201355.","journal-title":"Neuromuscul Disord"},{"key":"1503_CR8","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1542\/peds.2006-1400","volume":"119","author":"AS Daftary","year":"2007","unstructured":"Daftary AS, Crisanti M, Kalra M, Wong B, Amin R. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy. Pediatrics. 2007;119:e320\u20134.","journal-title":"Pediatrics."},{"key":"1503_CR9","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2106\/JBJS.L.01577","volume":"95","author":"DE Lebel","year":"2013","unstructured":"Lebel DE, Corston JA, McAdam LC, Biggar WD, Alman BA. Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up. J Bone Jt Surg Am. 2013;95:1057\u201361.","journal-title":"J Bone Jt Surg Am"},{"key":"1503_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.nmd.2008.03.002","volume":"18","author":"LW Markham","year":"2008","unstructured":"Markham LW, Kinnett K, Wong BL, Woodrow Benson D, Cripe LH. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord. 2008;18:365\u201370.","journal-title":"Neuromuscul Disord"},{"key":"1503_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/archdischild-2015-308654","volume":"101","author":"CL Wood","year":"2015","unstructured":"Wood CL, Straub V, Guglieri M, Bushby K, Cheetham T. Short stature and pubertal delay in Duchenne muscular dystrophy. Arch Dis Child. 2015;101:101\u20136.","journal-title":"Arch Dis Child"},{"key":"1503_CR12","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","volume":"68","author":"WM King","year":"2007","unstructured":"King WM, Ruttencutter R, Nagaraja HN, Matkovic V, Landoll J, Hoyle C, et al. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology. 2007;68:1607\u201313.","journal-title":"Neurology."},{"key":"1503_CR13","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/1097-4598(200009)23:9<1344::AID-MUS4>3.0.CO;2-F","volume":"23","author":"MD Bonifati","year":"2000","unstructured":"Bonifati MD, Ruzza G, Bonometto P, Berardinelli A, Gorni K, Orcesi S, et al. A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve. 2000;23:1344\u20137.","journal-title":"Muscle Nerve"},{"key":"1503_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.nmd.2012.07.009","volume":"22","author":"MM Rutter","year":"2012","unstructured":"Rutter MM, Collins J, Rose SR, Woo JG, Sucharew H, Sawnani H, et al. Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure. Neuromuscul Disord. 2012;22:1046\u201356.","journal-title":"Neuromuscul Disord"},{"key":"1503_CR15","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/jbmr.410","volume":"26","author":"A Rufo","year":"2011","unstructured":"Rufo A, Del Fattore A, Capulli M, Carvello F, De Pasquale L, Ferrari S, et al. Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Min Res. 2011;26:1891\u2013903.","journal-title":"J Bone Min Res"},{"key":"1503_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/jpepsy\/jsg038","volume":"28","author":"NE Nereo","year":"2003","unstructured":"Nereo NE, Fee RJ, Hinton VJ. Parental stress in mothers of boys with duchenne muscular dystrophy. J Pediatr Psychol. 2003;28:473\u201384.","journal-title":"J Pediatr Psychol"},{"key":"1503_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/adc.76.6.495","volume":"76","author":"MR Zacharin","year":"1997","unstructured":"Zacharin MR, Warne GL. Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets. Arch Dis Child. 1997;76:495\u20139.","journal-title":"Arch Dis Child"},{"key":"1503_CR18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1212\/WNL.56.8.1075","volume":"56","author":"GM Fenichel","year":"2001","unstructured":"Fenichel GM, Griggs RC, Kissel J, Kramer TI, Mendell JR, Moxley RT, et al. A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy. Neurology. 2001;56:1075\u20139.","journal-title":"Neurology."},{"key":"1503_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/13685538.2013.858113","volume":"17","author":"C Pexman-Fieth","year":"2014","unstructured":"Pexman-Fieth C, Behre HM, Morales A, Kan-Dobrosky N, Miller MG. A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. Aging Male. 2014;17:1\u201311.","journal-title":"Aging Male"},{"key":"1503_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/adc.66.2.197","volume":"66","author":"B Moorthy","year":"1991","unstructured":"Moorthy B, Papadopolou M, Shaw DG, Grant DB. Depot testosterone in boys with anorchia or gonadotrophin deficiency: effect on growth rate and adult height. Arch Dis Child. 1991;66:197\u20139.","journal-title":"Arch Dis Child"},{"key":"1503_CR21","doi-asserted-by":"crossref","unstructured":"Wood CL, Cheetham TD, Guglieri M, Bushby K, Owen C, Johnstone H, et al. Testosterone treatment of pubertal delay in Duchenne muscular dystrophy. Neuropediatrics. 2015;46.","DOI":"10.1055\/s-0035-1563696"},{"key":"1503_CR22","unstructured":"Northstar network. 2018. https:\/\/www.northstardmd.com\/about.html ."},{"key":"1503_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17:251\u201367.","journal-title":"Lancet Neurol"},{"key":"1503_CR24","unstructured":"Sustanon SMPC. https:\/\/www.medicines.org.uk\/emc\/product\/5373\/smpc\/ . Accessed 4 Oct 2018."},{"key":"1503_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-2-12","volume":"2","author":"MJ Atkinson","year":"2004","unstructured":"Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, et al. Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease. Heal Qual Life Outcomes. 2004;2:12.","journal-title":"Heal Qual Life Outcomes"},{"key":"1503_CR26","doi-asserted-by":"crossref","unstructured":"Opstal SL, Jansen M, van Alfen N, de Groot IJ. Health-related quality of life and its relation to disease severity in boys with Duchenne muscular dystrophy:: satisfied boys, worrying parents--a Case-control study. J Child Neurol. 2013.","DOI":"10.1177\/0883073813506490"},{"key":"1503_CR27","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/dmcn.12213","volume":"55","author":"A Mayhew","year":"2013","unstructured":"Mayhew A, Mazzone ES, Eagle M, Duong T, Ash M, Decostre V, et al. Development of the performance of the upper limb module for Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55:1038\u201345.","journal-title":"Dev Med Child Neurol"},{"key":"1503_CR28","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/dmcn.12220","volume":"55","author":"AG Mayhew","year":"2013","unstructured":"Mayhew AG, Cano SJ, Scott E, Eagle M, Bushby K, Manzur A, et al. Detecting meaningful change using the north star ambulatory assessment in Duchenne muscular dystrophy. Dev Med Child Neurol. 2013;55:1046\u201352.","journal-title":"Dev Med Child Neurol"},{"key":"1503_CR29","volume-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"WW Greulich","year":"1959","unstructured":"Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. California: Stanford University Press; 1959.","edition":"2"},{"key":"1503_CR30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1542\/peds.66.6.918","volume":"66","author":"PM Duke","year":"1980","unstructured":"Duke PM, Litt IF, Gross RT. Adolescents\u2019 self-assessment of sexual maturation. Pediatrics. 1980;66:918\u201320.","journal-title":"Pediatrics."},{"key":"1503_CR31","unstructured":"PedsQL. http:\/\/www.pedsql.org\/pedsqladmin.html ."},{"key":"1503_CR32","unstructured":"StataCorp. Stata Statistical Software: Release 13. 2013."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1503-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1503-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1503-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T21:04:00Z","timestamp":1663362240000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1503-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1503"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1503-x","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"12 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A favourable ethical opinion was obtained from the York NHS Research Ethics Committee (REC) prior to the start of the trial (15\/NE\/0332). Patients and their families were informed of this study verbally and with a patient information sheet and then given the opportunity to have any questions about the study answered by the trial investigators. Written informed consent was obtained from the parent(s)\/guardian(s) of the boys and an assent process appropriate to the age of each boy was carried out, with the permission of the parent(s)\/guardian(s) and where the child was intellectually capable.For children too young to consent but willing to assent the appropriate assent form was used. The original signed consent and assent forms will be retained in the Investigator Site File, with a copy in the clinical notes and a copy provided to the participant. The participants also specifically consented to their GP being informed of their participation in the study and additionally were given the option of consenting to an additional blood sample being taken for the Biobank.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written consent for their anonymised data to be published and disseminated appropriately. Written informed consent for publication of patient data was provided by the parents or legal guardians of underage participants on their behalf.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no disclosures or competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"131"}}